Toronto Dominion Bank Immatics N.V. Transaction History
Toronto Dominion Bank
- $58 Billion
- Q2 2025
A detailed history of Toronto Dominion Bank transactions in Immatics N.V. stock. As of the latest transaction made, Toronto Dominion Bank holds 2,912,390 shares of IMTX stock, worth $16.9 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
2,912,390
Previous 2,973,032
2.04%
Holding current value
$16.9 Million
Previous $13.4 Million
16.86%
% of portfolio
0.03%
Previous 0.03%
Shares
2 transactions
Others Institutions Holding IMTX
# of Institutions
74Shares Held
93.6MCall Options Held
158KPut Options Held
0-
T. Rowe Price Investment Management, Inc. Baltimore, MD18.3MShares$106 Million0.06% of portfolio
-
Suvretta Capital Management, LLC New York, NY12MShares$69.9 Million2.23% of portfolio
-
Baker Bros. Advisors LP New York, NY10.2MShares$59.1 Million0.55% of portfolio
-
Perceptive Advisors LLC New York, NY9.38MShares$54.5 Million2.22% of portfolio
-
Rtw Investments, LP New York, NY6.97MShares$40.5 Million0.58% of portfolio
About Immatics N.V.
- Ticker IMTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,227,000
- Market Cap $443M
- Description
- Immatics N.V., a clinical-stage biopharmaceutical company, focuses on the discovery and development of T cell receptor (TCR) based immunotherapies for the treatment of cancer in the United States. The company is developing targeted immunotherapies with a focus on treating solid tumors through two distinct treatment modalities, such as adoptive c...